输液容器用改性PP，最绕不开的一对矛盾是：透明靠降低结晶度，耐灭菌又靠高结晶度，两头没法同时拉满。这篇把透明度与蒸汽/辐照/EO 灭菌的机理对拉讲透，并把低温跌落、吊耳应力、药液相容与可沥滤物做成一张可查的验证路径。
"我们这款输液袋原来用的透明料，蒸汽灭完菌怎么雾度上来了，吊起来还有点发白？"
这是关于输液容器最常被问的一句。它背后是一个被反复验证的判断：输液容器选料踩得最多的坑，是把"透明"和"耐灭菌"当成两个能各自满足的指标——在 PP 上，它们是一对反向指标，谁也不能两头拉满。
失效现场也很典型。一类是"看着透、灭完不透"：粒子和样件按透明牌号验收都过了，进蒸汽灭菌或辐照后雾度回升、甚至发黄。另一类是"装得下、摔不得"：大容量薄壁袋在冷藏与运输的低温下跌落开裂，或者吊耳悬挂处从应力集中点起裂。这两类返工，都不是"料差了"一句话能解释的。
一、输液容器的工况六维：温度是双向的，透明与耐灭菌互相拉扯
核心结论：输液容器用改性PP，六维里温度和外观两维最紧，而且这两维方向相反——耐灭菌要的是高结晶度，透明要的是低结晶度。
先把六个数报齐，材料方向才立得住。
| 维度 | 输液瓶/袋的实际工况 | 对材料的要求 |
|---|
| 温度 | 双向：蒸汽灭菌常到 134℃、反复循环；冷藏与运输低到 2–8℃；EO 与辐照为常温 | 耐热与耐低温两头都要，灭菌高温是硬考验 |
| 载荷 | 悬挂自重 + 内压（加压输注）+ 跌落冲击；吊环/吊耳是应力集中区 | 环刚度、吊耳抗冲击、密封不渗漏 |
| 介质 | 各类药液：含电解质、含脂溶性成分、含防腐剂；脂溶性药液对添加剂的萃取最强 | 耐药液相容、低可沥滤物 |
| 寿命 | 一次性使用，但货架期以年计，保存期内不得漂移 | 析出与性能不随货架期走 |
| 外观 | 药液、异物、气泡必须目视看得清；透明牌号雾度 ≤15% | 低雾度，且灭菌后仍要达标 |
| 合规 | 医疗器械；重金属 ≤1.0 μg/mL、钛 ≤0.01%、紫外 220–240 nm 吸光度 ≤0.08 | 洁净、低析出、可追溯 |
六维里外观和温度是互相拉扯的两维：透明逼着结晶度往下走，灭菌稳定性逼着结晶度往上走。这两维的优先级定错，后面所有方案都白做。
一个内行细节：透明医用 PP 的雾度验收常按雾度 ≤15%（YY/T 0242-2007）作口径，透光率按实际壁厚与成型条件实测比对——但这个数通常是灭菌前测的。蒸汽灭菌会改变结晶状态，同一只瓶子的雾度会漂。所以验收文件上要写"灭菌后复测"。
二、材料路线对比：医用无规共聚PP、均聚PP 与 PVC、PETG、玻璃，各管哪类输液容器
核心结论：输液容器的材料路线不是"谁更好"的题，是"谁能避开哪条短板"的分工题——PP 的强项是合规与可回收，短板是天生的半透、辐照略黄、阻隔有限。
把能走的路线并列出来，只做分工陈述，不排优劣。
| 路线 | 透明与灭菌特点 | 主要顾虑 | 典型用途 |
|---|
| 医用无规共聚 PP | 半透（透明牌号雾度 ≤15%）；γ / EO / 蒸汽均可；可回收 | 透明与耐灭菌对拉；辐照略黄变 | 输液瓶、硬质容器、部分袋型 |
| 医用均聚 PP | 刚性高、耐热好，但更不透明 | 透明性差，靠壁厚与成型补 | 对透明要求不高的容器、配件 |
| 医用 PVC（传统输液袋） | 透明度优；γ / EO / 蒸汽 | 含增塑剂，DEHP 析出争议 | 传统软袋、输注管路 |
| PETG | 透明度优，耐辐照不黄变 | 耐热有限，高温灭菌受限 | 包装、诊断件、部分输液件 |
| COC/COP | 高透明、低析出、耐辐照 | 成本与韧性的平衡 | 高端包装、诊断 |
| 玻璃瓶 | 惰性、可视、耐蒸汽 | 重量与破损风险 | 注射液瓶、高端输液 |
| 多层共挤膜 | 阻隔层 + 聚烯烃层复合 | 回收与工艺更复杂 | 高阻隔软袋 |
文字版结论：PVC 因成本与透明度仍占输注袋最大份额；PETG 耐辐照不黄变，但耐热有限；PP 合规好、可回收，但天生不完全透明，要把球晶细化到可见光波长以下才做得出透明。据公开资料（B 级行业报告），聚烯烃类容器比 PVC 贵约 25–35%，换来的是无增塑剂、耐脂溶性药液更好。
三、★ 选型判据表：输液容器的八项门限，每项带验证方法
核心结论：输液容器用改性PP的判据不是一条，是八项，而且每一项都必须带着"怎么测、测到多少算过"一起看，否则选型等于没选。
下面这张表是全篇最该收藏的部分，注意第三列"验证方法·标准号"。
| 指标 | 门限值（典型） | 验证方法·标准号 | 常见失效 | 通行解法 |
|---|
| 透明度 / 雾度 | 透明牌号雾度 ≤15% | YY/T 0242-2007；灭菌后复测 | 灭菌后雾度回升、看不清药液 | 成核体系细化球晶 + 稳结晶 |
| 拉伸屈服 / 弯曲模量 | 拉伸屈服 ≥21 MPa；弯曲模量 ≥750 MPa | T/CSG 002-2020 | 薄壁变形、支撑不足 | 适度填充保刚性 |
| 缺口冲击 | ≥4 kJ/m² | T/CSG 002-2020（冲击按 GB/T 1843） | 低温跌落破裂 | 增韧 + 控低温韧性 |
| 可沥滤物（脂溶性最严） | 正己烷不挥发物 ≤100 mg | T/CSG 002-2020 | 脂溶性药液萃取添加剂 | 低析出、低灰分医用级 |
| 耐内压与密封 | 加压输注不渗漏、吊耳不开裂 | 产品标准 + 内压/密封试验 | 吊耳应力开裂、渗漏 | 结构加强 + 降应力集中 |
| 耐低温跌落 | 冷藏与运输温度下跌落不破 | 低温跌落试验（按产品标准） | 低温 + 大容积 + 薄壁开裂 | 增韧 + 壁厚/加强筋 |
| 耐化学消毒剂 | 擦拭/浸泡后无开裂发白 | 消毒剂接触试验 | 表面发白、应力开裂 | 耐介质体系 |
| 洁净与可追溯 | 低灰分、低催化剂残留 | T/CSG 002-2020；YY/T 0242 | 析出污染药液 | 医用级洁净包装 |
文字版结论：八项里透明度和可沥滤物最该先定——前者跟着灭菌方式走，后者跟着药液类型走，都必须在选型阶段锁死，而不是试产时才发现。把这张表当体检单，缺一项不判合格，比样件试出来再回头找原因省钱得多。
四、透明度与耐灭菌的对拉：越透明越不耐灭，机理在这里
核心结论：PP 要透明，机制是把结晶尺寸做到小于可见光波长；而耐热与灭菌稳定恰恰依赖高结晶度——"越透明 → 结晶度越低 → 耐蒸汽灭菌与尺寸稳定越差"，这才是那对反向指标的本质。
这一段是整篇的核心，必须把机理讲清。PP 天生的半透明，来自球晶对光的散射。要透明，通行两个手段：无规共聚 PP（引入共聚单体打乱结晶规整性）+ 成核剂（细化球晶到小于可见光波长）。这两个手段的代价是同一个——结晶度与结晶完善程度被压低。而耐蒸汽灭菌、耐反复热循环、尺寸稳定，恰恰靠高结晶度带来的耐热与抗蠕变。所以拿低结晶换透明，等于同时削弱了最该有的耐热与灭菌稳定性。
三种灭菌方式对透明度的影响完全不同，列成可查表：
| 灭菌方式 | 温度与原理 | 对透明度 / 尺寸的后果 | 对配方的要求 | 何时不宜 |
|---|
| 环氧乙烷 EO | 常温气相，对材料温和 | 温度低，对透明度最友好；但残留解析周期长 | 几乎不挑 PP 基体，但透气包装与解析要稳 | 急交付、解析场地受限 |
| 辐照（γ / 电子束） | 常温，效率高、无残留 | 断链 + 氧化生成共轭双键 → 黄变，直接破坏目视检查 | 必须上耐辐照稳定体系 | 要求高透明又高剂量辐照 |
| 蒸汽高温（高压蒸汽） | 常到 134℃、多次循环 | 高温改变结晶状态，雾度可能回升、尺寸变化 | 按高耐热、低析出、稳结晶配 | 长期 120℃ 以上反复蒸汽 |
辐照黄变的机理（本篇用足素材库核心专题，不自编数值）：高能射线优先打断 PP 主链 C–C 键 → 分子量下降 → 断裂伸长率与冲击强度下降；氧化生成共轭双键发色团 → 黄变。通用 PP 的断链速率远高于交联，所以表现是又黄又脆。对策有四个方向：主抗氧剂（受阻酚）+ 辅助抗氧剂（亚磷酸酯）+ HALS，⚠️ 但酚类抗氧剂与 HALS 并用会产生深黄，这是反直觉的一条；无规共聚引入 2–3% 乙烯降低结晶度、促进自由基复合，并选窄分子量分布树脂；工艺上用电子束替代 γ 射线、氮气氛围、剂量由 25 kGy 降至 15 kGy；耐受水平上，未稳定 PP 约 20 kGy，辐射稳定 PP 可达 20–50 kGy。
★ 必须否定的一处常见做法：很多人以为"想要透明就用无规共聚 PP"就讲完了。错。无规共聚保住了透明，但灭菌后的尺寸与透明度稳定性要靠成核体系与牌号选择来补——无规共聚把结晶度压低了，蒸汽一加热，结晶状态重新调整，雾度就可能回升。做完灭菌不复测透明度的选型，是不成立的。 透明牌号不是"选个无规共聚就行"，是"无规共聚 + 成核 + 灭菌后复测"三件事一起做。
五、常见失效与根因：雾度回升、低温跌落裂、吊耳开裂，三条根因
核心结论：三大失效——灭菌后雾度回升、低温跌落破裂、吊耳应力开裂——根因几乎都不在"料差了"，而在透明与耐灭菌没对齐、低温韧性没给够、应力集中没压住。
失效一：灭菌后雾度回升、发黄。 根因是配方没按"稳结晶 + 耐蒸灭/耐辐照"体系配，或酚类抗氧剂与 HALS 并用产生深黄；蒸汽灭菌的高温让结晶状态重新调整，也把雾度推高。先查灭菌方式与稳定体系，再查料的结晶取向。
失效二：低温 + 大容积 + 薄壁，跌落破裂。 根因在韧性没给够、壁厚与加强筋没设计好。冷藏与运输的低温、大容积液体的冲击载荷、薄壁——三者单独都可控，叠在一起就超出很多透明 PP 的韧性余量。
失效三：吊环/吊耳悬挂应力开裂。 根因在悬挂受力点本身就是应力集中区，吊耳转角、壁厚突变、浇口残余应力都在这里放大。这是开裂的典型起点，不是"料脆了"那么简单，是结构与料一起没对齐。
同行抄不走的一个判断：输液容器上"透明"和"耐灭菌"不是两个独立指标，是同一个结晶度旋钮的两头。把它们当成两张清单分别验收，最后一定在灭菌后复测这一关卡住——所以这一关必须前置。
六、验证顺序：先定灭菌方式与药液类型，灭菌后复测是一票否决
核心结论：验证顺序最该先定的是"灭菌方式 + 药液类型"，而灭菌后的透明度与尺寸复测是不可省略的一票否决步——只测灭菌前，等于没测。
这一段同行几乎没人写，但它是换料能不能省钱、能不能过注册的关键。顺序错了，问题会在最后一步集中爆出来。
`
① 定灭菌方式与药液类型 蒸汽 / EO / 辐照？药液含脂溶性 / 电解质 / 防腐剂？
↓ 这两步不定，后面全是猜
② 灭菌后透明度与尺寸复测 雾度、透光率、尺寸——灭后再测（一票否决）
↓ 这一步不过，前面白做
③ 低温跌落与吊耳冲击 冷藏与运输温度下的跌落 + 吊耳悬挂冲击
↓ 这一步不过，退回改增韧与结构
④ 耐内压与密封 加压输注、吊耳受力、密封不渗漏
↓
⑤ 药液相容与可沥滤物 脂溶性药液对应的一档先过，再看具体药液
↓
⑥ 装配与悬挂整机验证 吊挂、标签与印刷附着、不脱屑、整机
↓
⑦ 临床前验证
`
每一步都有"不过就退回上一级"的判据。最常见的错误是跳过 ②——只测灭菌前的粒子典型值与样件透明验收，就拿去量产，灭菌后整批雾度回升或尺寸漂移才暴露。灭菌后复测，是输液容器和工业件最本质的区别之一。
文字版结论：验证顺序 灭菌方式+药液类型 → 灭菌后复测 → 跌落吊耳 → 内压密封 → 药液相容 → 整机 → 临床前。灭菌后复测必须放在最前且一票否决，因为它最可能直接判废。
七、反向诚实：极高透明度兼高剂量辐照、长期 120℃ 以上蒸汽、或极高阻隔，这类件不该用改性PP
核心结论：遇到"极高透明度 + 高剂量辐照""长期 120℃ 以上反复蒸汽""极高阻隔"三件事之一，这个件就不该硬撑改性 PP，要换路线。
讲完能做的，必须讲不能做的。
| 出现的情况 | 为什么改性PP不合适 | 该往哪走 |
|---|
| 要求极高透明度且必须耐高剂量辐照 | 辐照黄变与透明是反方向；耐辐照体系也要牺牲一部分透明 | 走 PETG、COC/COP 等耐辐照不黄变路线 |
| 要求长期 120℃ 以上反复蒸汽灭菌 | PP 耐热上限就在那条线附近，反复循环的尺寸变化与雾化难压住 | 换更高耐热的工程塑料或玻璃容器 |
| 要求极高阻隔（对氧气/水汽敏感的药品） | PP 本征阻隔有限，靠改性提升幅度有限 | 走多层共挤、铝箔/PA 复合或玻璃 |
| 脂溶性药液长期接触且要求极低析出 | PP 中的添加剂在脂溶性介质下更易被萃取 | 低析出专用牌号，或换更高惰性的材料评估 |
规律是一致的：只要出现"两个方向相反的要求同时要"，就说明这个件不该用 PP 硬撑。 遇到这种情况，我们的做法是先把这条讲清楚，再谈有没有折中空间。
八、换料风险清单：从模具收缩率到灭菌后复测，七项先看再动
核心结论：决定试医用改性PP做输液容器之前，要动的不是性能，是模具、工艺与验证顺序三块，其中最该先谈的是灭菌后透明度复测。
| 要动的项 | 需要确认什么 | 不做会怎样 |
|---|
| 模具收缩率 | 新料收缩率与原方案的差，薄壁件尤其敏感 | 尺寸超差，装配对不上 |
| 浇口与排气 | 透明料对浇口、排气更敏感 | 熔接线、气痕、透明件发雾 |
| 料温与模温 | 透明/成核体系的工艺窗口不同 | 结晶不均、雾度超标 |
| 干燥 | 按具体体系定 | 银丝、气泡 |
| 保压与脱模 | 薄壁件顶出易拉伤 | 变形、顶白 |
| 色差 | 医用件色板先确认 | 批次色差争议 |
| 验证顺序 | 先小样 → 灭菌后复测 → 短射 → 批量 | 风险全部压到最后一步集中爆发 |
文字版结论：换料要动的是模具、工艺、色差三块，其中最该先谈的是验证顺序里的"灭菌后透明度复测"。跳过小样直接试模，等于把成本提前花出去；跳过灭菌后复测直接批量，一次失败就是整批报废——输液容器上这比工业件贵得多。
九、一页纸汇报表：输液容器，直接贴进技术评审
核心结论：这张表让技术员能把结论直接往上报，不必重新组织语言——判断标准只有一条，客户拿它能不能在一次会里把材料方向定下来。
| 场景 | 推荐路线 | 关键指标 | 验证标准 | 需先确认的条件 |
|---|
| 输液瓶（蒸汽灭菌） | 医用透明无规共聚 PP + 成核 + 耐蒸灭体系 | 雾度 ≤15%（灭菌后复测）；拉伸屈服 ≥21 MPa | YY/T 0242；T/CSG 002-2020 | 是否反复蒸汽循环 |
| 输液袋（EO 灭菌） | 医用透明 PP，几乎不挑基体 | 雾度 ≤15%；EO 残留限量 | YY/T 0242；ISO 10993-7 | 解析周期与场地 |
| 输液容器（辐照灭菌） | 医用无规共聚 PP + 耐辐照稳定体系 + 成核透明 | 雾度 ≤15%；辐射后黄变指数 ≤20（25 kGy） | YY/T 0242；ISO 10993 系列 | 灭菌剂量、是否要求高透明 |
| 脂溶性药液容器 | 低析出医用 PP，脂溶性介质按最严一档控 | 正己烷不挥发物 ≤100 mg | T/CSG 002-2020 | 药液成分、接触时长 |
| 高阻隔药液容器 | 多层共挤 / PP 复合阻隔层 | 透氧透湿达标 | 产品标准 + 阻隔试验 | 阻隔等级要求 |
文字版结论：这张表让技术员把"灭菌方式 + 药液类型"两个前提一次性报齐，再推材料方向。前提没报齐就定料，是输液容器选型返工率最高的动作。
十、这个件上最容易出问题的，往往不是料
输液容器行业最常见的早期失效是灭菌后雾度回升与吊耳应力开裂，而这两类问题里，由材料本身引起的比例并不高。前者判据写得清楚：透明牌号雾度要落在 YY/T 0242-2007 门限内（灭菌后复测），机理是蒸汽高温改变结晶状态、或辐照断链氧化生成发色团；通行解法是无规共聚 + 成核细化球晶 + 稳定体系。吊耳开裂则多半要从结构与应力集中去找。
行业通行的做法，是把"灭菌方式"和"药液类型"这两件前提先定下来，再定基材档位、透明成核体系与稳定剂方向——顺序反了，问题会一直漂。这里要说清一个责任边界：材料供应商能做的是配方层面的低析出与批次一致性，药液相容与生物学评价的主体责任在器械企业。
宁波市科隆新材料有限公司在这个方向上常供医用方向的 PP 基材与改性粒子，覆盖透明化、耐辐照稳定、低析出等方向，按客户的产品标准与灭菌方式给出基材档与助剂方向建议，主要解决"透明与耐灭菌没对齐"这一类问题；配方按件的工况调，可以配合做小样比对与试模。
常见问答
问：输液袋蒸汽灭完菌雾度回升，是不是料不行？
答：多半是配方没按"稳结晶 + 耐蒸灭"体系配，或者无规共聚把结晶度压得太低、蒸汽一加热结晶状态重新调整。先查灭菌温度与循环次数、成核体系，再看料的结晶取向——这是配方与成型问题。
问：脂溶性药液会不会把添加剂萃取出来？
答：会，而且脂溶性介质比水性介质更容易萃取。通行做法是按最严一档先过（如正己烷不挥发物 ≤100 mg，T/CSG 002-2020），再针对具体药液做相容性评估。这与食品侧"油性模拟物最严"是同一机理，只是本篇讲药液侧。
问：EO 灭菌和辐照怎么选更省心？
答：EO 对材料温和、几乎不挑 PP 基体，但残留解析周期长、要管住限量；辐照效率高、无残留，但必须上耐辐照配方，否则透明件又黄又雾。选哪个，看交付节奏和件对透明的容忍度。
| 工况 | 关键判据 | 科隆常规供应 |
|---|
| 输液瓶（蒸汽灭菌） | 雾度 ≤15%（灭菌后复测）；拉伸屈服 ≥21 MPa | 医用透明无规共聚 PP + 成核 + 耐蒸灭方向 |
| 输液容器（EO/辐照） | EO 残留限量 / 辐射后黄变指数 ≤20（25 kGy） | 医用透明 PP，按灭菌方式调体系 |
| 脂溶性药液容器 | 正己烷不挥发物 ≤100 mg | 低析出医用 PP 方向 |
想提醒一句：件出问题，最常见的错法是先换料。雾度回升、跌落开裂、吊耳开裂——每一条的原因都不止一个。先定位，再换料；顺序反了，往往换了几轮还在原地。
最后说三句
第一，透明和耐灭菌在 PP 上是一对反向指标，不是两张清单。 它们共用同一个结晶度旋钮，谁也不能两头拉满——先定哪一头更不能掉。
第二，灭菌方式不同，透明度的后果不同。 EO 对透明最友好，辐照会黄变、蒸汽会让雾度回升；配方要跟着灭菌方式走。
第三，灭菌后必须复测透明度与尺寸。 只测灭菌前等于没测，这一关要前置于跌落、内压与相容性验证。
下一篇讲冰箱内胆与洗衣机内桶——那个件最怕的不是透明度，是耐洗涤剂 ESC 与低温冲击。
关于我们
选型卡住，通常卡在很具体的一步。
是输液容器到底要透明还是要耐蒸灭，是成核体系配了又怕蒸汽后雾度回升，是吊耳应力开裂查了料又查模温——说清卡在哪一步，比说"要一种好料"有用得多。
宁波市科隆新材料有限公司，自产改性聚丙烯（PP）造粒，覆盖均聚 / 无规共聚 / 抗冲共聚三档基材，以及透明化、耐辐照稳定、低析出、填充、玻纤增强、增韧、阻燃等改性方向；兼营各大石化厂 PP 树脂、副牌料与大包料。
For infusion containers made of modified PP, the most unavoidable contradiction is: transparency relies on reducing crystallinity, while sterilization resistance relies on high crystallinity, making it impossible to fully achieve both. This article explains in depth the mechanisms of balancing transparency with steam/irradiation/EO sterilization, and presents a verifiable checklist path covering low-temperature drop tests, handle stress, drug solution compatibility, and extractables.
Our infusion bags originally used transparent material, but after steam sterilization, why has the cloudiness increased, and why do they appear a bit white when hung up?
This is the most frequently asked question about infusion containers. Behind it is a judgment that has been repeatedly verified: the most common pitfall in selecting materials for infusion containers is treating 'transparency' and 'sterilization resistance' as two separate criteria that can each be fully satisfied — for PP, they are a pair of opposing indicators, and neither can be maximized simultaneously.
The failure sites are also very typical. One type is 'looks transparent, but not transparent after sterilization': the particles and sample parts passed inspection according to transparent grades, but after steam sterilization or irradiation, the haze returns or they even turn yellow. The other type is 'fits, but can't be dropped': large-capacity thin-walled bags crack when dropped at low temperatures during refrigeration and transportation, or cracks start from stress concentration points at hanging ears. These two types of rework cannot be explained simply by saying 'the material is bad.'
1. The six conditions of infusion containers: Temperature is bidirectional, and transparency and sterilization resistance tug at each other.
Core conclusion: For infusion containers using modified PP, temperature and appearance are the most critical dimensions in six aspects, and these two dimensions are opposite—resistance to sterilization requires high crystallinity, while transparency requires low crystallinity.
First report all six numbers, only then can the material direction be established.
| Dimension | Actual operating conditions of infusion bottles/bags | Requirements for the materials |
|---|
| Temperature | Bidirectional: Steam sterilization is often up to 134°C with repeated cycles; refrigeration and transportation down to 2–8°C; EO and irradiation are at room temperature | Needs to withstand both heat and cold, sterilization at high temperatures is a tough test |
| Load | Suspended self-weight, internal pressure (pressurized injection), drop impact; lifting ring/lug is a stress concentration area | Ring stiffness, lug impact resistance, leak-proof sealing |
| Medium | Various types of medicinal liquids: containing electrolytes, containing fat-soluble components, containing preservatives; fat-soluble medicinal liquids have the strongest extraction effect on additives | Drug-resistant liquid compatible, low filtrable solids |
| Lifespan | For single use, but the shelf life is measured in years, and it must not deviate during the storage period | Precipitation and performance do not change with shelf life |
| Appearance | The liquid medicine, foreign objects, and bubbles must be clearly visible to the naked eye; the haze of the transparent label should be ≤15% | Low turbidity, and it must still meet standards after sterilization |
| Compliance | Medical devices; heavy metals ≤1.0 μg/mL, titanium ≤0.01%, ultraviolet 220–240 nm absorbance ≤0.08 | Clean, low deposition, traceable |
In six dimensions, appearance and temperature are two dimensions that pull against each other: transparency forces crystallinity to go down, while sterilization stability forces crystallinity to go up. If the priorities of these two dimensions are set incorrectly, all subsequent plans will be in vain.
A professional detail: The haze acceptance of transparent medical PP is often based on haze ≤15% (YY/T 0242-2007), with light transmittance compared to the actual wall thickness and molding conditions — but this number is usually measured before sterilization. Steam sterilization can change the crystallization state, causing the haze of the same bottle to drift. Therefore, the acceptance document should state 'retest after sterilization'.
2. Comparison of Material Routes: Medical random copolymer PP, homopolymer PP versus PVC, PETG, glass, which types of infusion containers for each tube
Core conclusion: The material choice for infusion containers is not a question of 'which is better,' but a matter of 'who can avoid which shortcomings'—PP's strengths are compliance and recyclability, while its weaknesses are inherent semi-permeability, slight yellowing after irradiation, and limited barrier properties.
List the routes that can be taken side by side, only making a division of labor statement, without ranking them.
| Route | Transparency and Sterilization Features | Main concern | Typical uses |
|---|
| Medical Random Copolymer PP | Semi-transparent (transparency haze ≤15%); γ / EO / steam all suitable; recyclable | Transparent and resistant to sterilization; slightly yellowed by irradiation | Infusion bottles, rigid containers, some types of bags |
| Medical homopolymer PP | High rigidity and good heat resistance, but more opaque | Poor transparency, supplemented by wall thickness and molding | Containers and accessories that do not require high transparency |
| Medical PVC (traditional infusion bag) | Good transparency; γ / EO / vapor | Contains plasticizers, controversy over DEHP leaching | Traditional soft bags and infusion sets |
| PETG | High transparency, resistant to radiation without yellowing | Limited heat resistance, high-temperature sterilization is restricted | Packaging, diagnostic parts, some infusion parts |
| COC/COP | High transparency, low precipitation, radiation resistant | Balance between cost and resilience | High-end packaging, diagnostics |
| Glass bottle | Inert, visible, steam-resistant | Weight and Risk of Damage | Injection vials, high-end infusion |
| Multilayer coextruded film | Barrier layer polyolefin layer composite | Recycling and processes are more complex | High barrier pouch |
Text Version Conclusion: PVC still holds the largest share of infusion bags due to cost and transparency; PETG does not yellow under irradiation but has limited heat resistance; PP is compliant and recyclable but naturally not fully transparent, requiring spherulites to be refined below the wavelength of visible light to achieve transparency. According to publicly available information (B-level industry report), polyolefin containers are about 25–35% more expensive than PVC, in exchange for being plasticizer-free and having better resistance to lipophilic drug solutions.
3. ★ Selection Criteria Table: Eight Thresholds for Infusion Containers, Each with a Verification Method
Key conclusion: The criteria for modified PP used in infusion containers are not just one, but eight items, and each must be considered together with 'how to measure, and how much counts as passing'; otherwise, choosing a type is equivalent to not choosing at all.
The table below is the part of the whole text most worth saving; pay attention to the third column 'Verification Method · Standard Number'.
| Indicator | Threshold Value (Typical) | Verification Method · Standard Number | Common Failures | Common solution |
|---|
| Transparency / Haze | Haze of transparent grade ≤15% | YY/T 0242-2007; Retest after sterilization | After sterilization, the turbidity increases again, and the medicine solution becomes unclear | Nucleation system refines spherulites Stabilizes crystallization |
| Tensile Yield / Bending Modulus | Tensile yield ≥21 MPa; bending modulus ≥750 MPa | T/CSG 002-2020 | Thin-walled deformation, insufficient support | Moderate filling ensures rigidity |
| Gap Shock | ≥4 kJ/m² | T/CSG 002-2020 (Impact according to GB/T 1843) | low-temperature impact fracture | Toughening Control low-temperature toughness |
| Filterable residue (most stringent for fat-soluble) | Non-volatile substances in n-hexane ≤100 mg | T/CSG 002-2020 | Fat-soluble drug liquid extraction additive | Low-extraction, low-ash medical grade |
| Pressure Resistance and Sealing | Pressurized infusion does not leak, lifting ears do not crack | Product Standard Internal Pressure/Sealing Test | Lifting lug stress cracking and leakage | Structural reinforcement Reduce stress concentration |
| Low-temperature drop resistant | Drop-resistant at refrigerated and transport temperatures | Low temperature drop test (according to product standards) | Low temperature Large volume Thin wall cracking | Toughening Wall Thickness / Ribs |
| Resistant to chemical disinfectants | No cracking or whitening after wiping/soaking | Disinfectant Contact Test | Surface whitening, stress cracking | Media-resistant system |
| Cleanliness and traceability | Low ash content, low catalyst residue | T/CSG 002-2020; YY/T 0242 | Precipitated contaminated medicine solution | Medical-grade clean packaging |
Text version conclusion: Among the eight items, transparency and filterable substances should be determined first—the former follows the sterilization method, the latter follows the type of solution. Both must be locked during the selection stage, rather than discovering them during trial production. Treat this table as a health check form; missing any item should be considered a fail. This is much more cost-effective than figuring out the cause after testing sample parts.
4. The trade-off between transparency and sterilization resistance: the more transparent, the less resistant to sterilization, the mechanism is here
Core conclusion: PP needs to be transparent, and the mechanism is to make the crystal size smaller than the wavelength of visible light; whereas heat resistance and sterilization stability precisely depend on high crystallinity — 'the more transparent → the lower the crystallinity → the worse the steam sterilization resistance and dimensional stability,' this is the essence of that pair of opposing indicators.
This section is the core of the whole article, and the mechanism must be clearly explained. PP is naturally semi-transparent, due to the scattering of light by spherulites. To achieve transparency, there are two methods: random copolymerization of PP (introducing comonomers to disrupt the regularity of crystallization) and nucleating agents (refining spherulites to smaller than the wavelength of visible light). The cost of these two methods is the same—both reduce the degree of crystallinity and the perfection of crystallization. However, resistance to steam sterilization, repeated thermal cycling, and dimensional stability depend precisely on the heat resistance and creep resistance brought by high crystallinity. Therefore, exchanging low crystallinity for transparency simultaneously weakens the heat and sterilization stability that are most needed.
The three sterilization methods have completely different effects on transparency, listed in a table for reference:
| Sterilization method | Temperature and Principle | Consequences of transparency/size | Requirements for the formula | When not suitable |
|---|
| Ethylene Oxide (EO) | Room temperature gas phase, gentle on materials | Low temperature is most friendly to transparency; but the residual resolution cycle is long. | Almost not picky about PP substrates, but the breathable packaging and analysis need to be stable | Urgent delivery, limited site for analysis |
| Irradiation (γ / electron beam) | Room temperature, high efficiency, no residue | Chain scission Oxidation generates conjugated double bonds → Yellowing, directly damages visual inspection | Must use radiation-resistant stable system | Requires high transparency and high-dose irradiation |
| Steam at high temperature (high-pressure steam) | Frequently reaches 134°C, multiple cycles | High temperatures change the crystalline state, haze may increase again, and size changes | Formulated for high heat resistance, low precipitation, and stable crystallization | Repeated steam above 120°C for a long time |
Mechanism of radiation-induced yellowing (this article uses the core topics from the material library, without creating any new values): High-energy rays preferentially break the C–C bonds in the PP main chain → molecular weight decreases → elongation at break and impact strength decrease; oxidation generates conjugated double-bond chromophores → yellowing. The chain scission rate of general PP is much higher than crosslinking, so the result is both yellow and brittle. There are four strategies: primary antioxidants (hindered phenols), secondary antioxidants (phosphite esters), HALS, ⚠️ but using phenolic antioxidants together with HALS produces deep yellow, which is counterintuitive; introducing 2–3% ethylene in random copolymers lowers crystallinity and promotes free radical recombination, and selecting resins with a narrow molecular weight distribution; in processing, use electron beam instead of γ-ray, nitrogen atmosphere, and reduce the dose from 25 kGy to 15 kGy; in terms of tolerance, unstabilized PP is around 20 kGy, while radiation-stabilized PP can reach 20–50 kGy.
★ A common practice that must be denied: Many people think that 'if you want transparency, just use random copolymer PP,' and that's it. Wrong. Random copolymer maintains transparency, but the dimensional and transparency stability after sterilization relies on the nucleation system and grade selection. Random copolymer lowers crystallinity, and once it is heated by steam, the crystalline state readjusts, and haze may return. Choosing grades without re-testing transparency after sterilization is invalid. Transparent grades are not just 'pick a random copolymer,' but 'random copolymer + nucleation + re-test after sterilization'—these three steps must be carried out together.
5. Common Failures and Root Causes: Haze recovery, low-temperature drop cracks, ear lug cracking, three root causes
Key Conclusion: The three major failures——haze recovery after sterilization, cracking from low-temperature drop, and stress cracking at the ear——are almost never due to 'material defects,' but rather because transparency and sterilization resistance were not aligned, low-temperature toughness was insufficient, and stress concentration was not controlled.
Failure 1: Haze increases and yellowing occurs after sterilization. The root cause is that the formulation was not matched according to the 'stable crystallization, steam/irradiation resistant' system, or phenolic antioxidants were used together with HALS causing deep yellowing; the high temperature of steam sterilization allows the crystalline state to readjust, also increasing the haze. First, check the sterilization method and the stabilizing system, then check the crystallization orientation of the material.
Failure mode 2: Low temperature, large volume, thin walls, rupture upon dropping. The root cause is insufficient toughness and poorly designed wall thickness and reinforcement ribs. Low temperature during refrigeration and transportation, impact loads from large-volume liquids, and thin walls—each factor alone is controllable, but when combined, they exceed the toughness margin of many transparent polypropylene products.
Failure Three: Stress cracking in lifting rings/lugs. The root cause is that the hanging stress points themselves are areas of stress concentration. The lug corners, sudden changes in wall thickness, and residual stresses from the gate all amplify here. This is a typical starting point for cracking, not simply that the material became brittle; it is that the structure and the material were not aligned together.
A judgment that peers can't copy: on an infusion container, 'transparent' and 'sterilization-resistant' are not two separate indicators, but the two ends of the same crystallinity knob. If you treat them as two separate checklists for inspection, you will inevitably get stuck at the stage of re-testing after sterilization—so this checkpoint must be positioned beforehand.
6. Verification sequence: First determine the sterilization method and type of solution. After sterilization, retesting can result in outright rejection.
Core Conclusion: The validation sequence should first determine the 'sterilization method and type of solution,' while the re-measurement of transparency and size after sterilization is a veto step that cannot be skipped — measuring only before sterilization is equivalent to not measuring at all.
Almost no peers write this section, but it is key to whether changing materials can save money and pass registration. If the order is wrong, problems will all come up at the final step.
`
① Determine sterilization method and type of solution Steam / EO / irradiation? Does the solution contain fat-soluble substances / electrolytes / preservatives?
↓ These two steps are uncertain, everything that follows is just a guess
② Re-measure transparency and size after sterilization: haze, light transmittance, size — re-measure after sterilization (one-vote veto)
↓ If this step fails, everything before it was done for nothing.
③ Low-temperature drop and lug impact Drop at refrigerated and transport temperatures Lug suspension impact
↓ This step is not passed, go back to increase toughness and adjust the structure
④ Pressure Resistance and Sealing Pressurized infusion, lug stress, no leakage in sealing
↓
⑤ Drug solution compatibility and filterable substances Fat-soluble drug solutions go through the first stage, then check the specific drug solution
↓
⑥ Assembly and Suspension Complete Machine Verification: Hanging, labels and print adhesion, no flaking, complete machine
↓
⑦ Preclinical validation
`
Every step has the criterion of 'just return to the previous level.' The most common mistake is skipping step ②—only testing the typical particle values before sterilization and accepting the sample visually, then moving on to mass production; only after sterilization does the whole batch's haze increase or dimensions drift, exposing the problem. Re-testing after sterilization is one of the most fundamental differences between infusion containers and industrial parts.
Text version conclusion: Verification sequence: sterilization method, type of medicinal solution → retesting after sterilization → drop test of ear loops → internal pressure sealing → medicinal solution compatibility → whole device → preclinical. Retesting after sterilization must be placed first and is a single-vote veto, because it is the most likely to directly deem the product defective.
7. Reverse honesty: Extremely high transparency combined with high-dose irradiation, long-term steam above 120°C, or extremely high barrier properties; such items should not use modified PP
Core conclusion: When encountering any one of 'extremely high transparency and high-dose irradiation,' 'repeated steam at over 120°C for a long time,' or 'extremely high barrier,' this part should not be forced to modify PP; a different approach should be chosen.
After talking about what can be done, it is necessary to talk about what cannot be done.
| The situation that occurred | Why is modified PP not suitable? | Which way should I go? |
|---|
| Requires extremely high transparency and must withstand high-dose irradiation | Irradiation yellowing and transparency are in opposite directions; radiation-resistant systems also have to sacrifice some transparency. | Pursue radiation-resistant, non-yellowing paths such as PETG and COC/COP |
| Requires repeated steam sterilization at above 120℃ for a long period | The heat resistance limit of PP is around that line, and the repeated cyclical dimensional changes and atomization are hard to suppress. | Switch to higher heat-resistant engineering plastics or glass containers |
| Requires high barrier (for drugs sensitive to oxygen/moisture) | PP's intrinsic barrier is limited, and the improvement achieved through modification is also limited. | Multilayer co-extrusion, aluminum foil/PA composite, or glass |
| Lipid-soluble drug solution long-term contact with a requirement for extremely low precipitation | Additives in PP are more easily extracted in lipophilic media | Low-precipitation-specific grade, or evaluate using more inert materials |
The pattern is consistent: whenever there are 'two opposing requirements being demanded at the same time,' it indicates that this part should not be forced to use PP. In such cases, our approach is to first clarify this point before discussing whether there is room for compromise.
VIII. Material Change Risk List: From mold shrinkage rate to post-sterilization retesting, review all seven items before taking action
Core conclusion: Before deciding to experiment with medical-grade modified PP for infusion containers, what needs to be addressed first is not performance, but the three areas of mold, process, and validation sequence, among which the one that should be discussed first is the re-measurement of transparency after sterilization.
| Items to move | What needs to be confirmed? | What will happen if I don't do it? |
|---|
| Mold shrinkage rate | The difference in shrinkage rate of the new material compared to the original plan, thin-walled parts are especially sensitive | The dimensions are out of tolerance, and the assembly does not fit. |
| Gate and Venting | Transparent materials are more sensitive to gates and venting | Weld lines, air marks, fogging of transparent parts |
| Material Temperature and Mold Temperature | The process windows of transparent/nucleating systems are different | Uneven crystallization, excessive haze |
| Dry | Decided according to the specific system | Silver threads, bubbles |
| Pressure Holding and Demolding | Thin-walled parts are easily scratched during ejection | Distortion, highlight |
| Color difference | Medical part color chart to be confirmed first | Batch color difference dispute |
| Verification order | First sample → Retest after sterilization → Short run → Mass production | All the risks are concentrated to explode at the final step |
Text version conclusion: Changing materials involves three aspects: molds, processes, and color difference, among which the first thing to discuss is the 'post-sterilization transparency re-test' in the verification sequence. Skipping small samples and going straight to mold trials is equivalent to spending the cost upfront; skipping the post-sterilization re-test and going straight to mass production means that a single failure will result in the entire batch being scrapped—this is much more costly for infusion containers than for industrial parts.
9. One-page report form: Infusion containers, directly included in the technical review
Core conclusion: This table allows technicians to report conclusions directly without having to reorganize their wording—the only criterion is whether the client can use it to finalize the material direction in a single meeting.
| Scene | Recommended Route | Key indicators | Verification Standard | Conditions that need to be confirmed first |
|---|
| Infusion bottle (steam sterilization) | Medical Transparent Random Copolymer PP Nucleating Steam Sterilization Resistant System | Haze ≤15% (retested after sterilization); tensile yield ≥21 MPa | YY/T 0242; T/CSG 002-2020 | Whether to repeat the steam cycle |
| Infusion bag (EO sterilized) | Medical-grade transparent PP, hardly selective of substrates | Fog density ≤15%; EO residue limit | YY/T 0242; ISO 10993-7 | Analysis Period and Site |
| Infusion container (radiation sterilized) | Medical random copolymer PP, radiation-resistant stable system, nucleated transparent | Haze ≤15%; yellowness index after radiation ≤20 (25 kGy) | YY/T 0242; ISO 10993 series | Sterilization dose, whether high transparency is required |
| Lipophilic drug solution container | Low-extractable medical PP, lipophilic media controlled according to the strictest standard | Non-volatile substances in n-hexane ≤100 mg | T/CSG 002-2020 | Liquid medicine ingredients, contact duration |
| High-barrier liquid medicine container | Multi-layer Co-extrusion / PP Composite Barrier Layer | Meets standards for oxygen and moisture permeability | Product Standard Barrier Test | Barrier level requirements |
Text version conclusion: This table allows technicians to report both 'sterilization method and type of solution' at once, and then determine the material direction. Deciding on the material without reporting all the prerequisites is the action with the highest rework rate in the selection of infusion containers.
10. The part of this item that is most prone to problems is often not the material.
The most common early failures in the infusion container industry are the recurrence of cloudiness after sterilization and stress cracking at the hanging ears, and among these two issues, the proportion caused by the material itself is not high. The criterion for the former is clearly written: the cloudiness of the transparent grade must fall within the threshold specified in YY/T 0242-2007 (retested after sterilization). The mechanism is that high-temperature steam changes the crystalline state or irradiation-induced chain scission and oxidation generate chromophores. The common solution is random copolymerization, nucleation to refine spherulites, and stabilizing the system. Cracking at the hanging ears mostly needs to be addressed from the structure and stress concentration.
The common industry practice is to first determine the 'sterilization method' and 'type of drug solution' as prerequisites, then decide on the substrate grade, transparent nucleation system, and stabilizer direction—if the order is reversed, problems will persist. Here, one responsibility boundary needs to be clarified: what material suppliers can do is ensure low precipitation and batch consistency at the formulation level, while the main responsibility for drug solution compatibility and biological evaluation lies with the device company.
Ningbo Cologne New Materials Co., Ltd. regularly supplies PP substrates and modified particles for medical applications in this area, covering directions such as transparency, radiation stability, and low extractables. They provide recommendations on substrate grades and additives according to the customer's product standards and sterilization methods, mainly addressing issues like 'transparency and sterilization resistance not being aligned.' Formulations can be adjusted according to specific operating conditions, and small-scale samples and mold trials can be conducted for comparison.
Frequently Asked Questions
Question: After sterilizing the infusion bag with steam, the mist density rises again. Does this mean the material is no good?
Answer: Most likely, the formulation was not prepared according to the 'stable crystallization, steam-resistant' system, or the random copolymerization reduced the crystallinity too much, so when steam is applied, the crystallization state readjusts. First, check the sterilization temperature and number of cycles, as well as the nucleation system, then look at the crystallization orientation of the material — this is an issue of formulation and molding.
Question: Will lipid-soluble drug solutions extract the additives?
Answer: Yes, and fat-soluble media are easier to extract than aqueous media. The common practice is to first test according to the strictest standard (for example, n-hexane non-volatile ≤100 mg, T/CSG 002-2020), and then conduct compatibility assessment for the specific drug solution. This is the same mechanism as the 'strictest oil simulant' on the food side, except that this article discusses the drug solution side.
Question: Which is more convenient to choose, EO sterilization or irradiation?
Answer: EO is gentle on materials and almost non-discriminatory to the PP matrix, but it has a long residual decomposition period and requires controlling the limit; irradiation is efficient with no residue, but a radiation-resistant formulation must be used, otherwise transparent parts will turn yellow and cloudy. Which one to choose depends on the delivery schedule and the parts' tolerance for transparency.
| Operating condition | Key criterion | Cologne regular supply |
|---|
| Infusion bottle (steam sterilization) | Haze ≤15% (retested after sterilization); tensile yield ≥21 MPa | Medical transparent random copolymer PP Nucleation Steam sterilization resistance orientation |
| Infusion container (EO/irradiation) | EO Residual Limit / Post-irradiation Yellowing Index ≤20 (25 kGy) | Medical transparent PP, system adjusted according to sterilization method |
| Lipophilic drug solution container | Non-volatile substances in n-hexane ≤100 mg | Low-extractable medical PP orientation |
A reminder: when there’s a problem with a part, the most common mistake is to change the material first. Increased haze, drop cracks, ear cracks—each of these issues has more than one cause. First identify the cause, then change the material; if the order is reversed, you often end up changing materials several times and still be in the same place.
Finally, say three sentences
First, transparency and sterilization resistance are a pair of opposing indicators for PP, not two separate checklists. They share the same crystallinity knob, and neither can be maximized at both ends—decide which end is more critical not to compromise first.
Secondly, different sterilization methods have different consequences for transparency. EO is the most friendly to transparency, irradiation causes yellowing, and steam can increase cloudiness; the formulation needs to follow the sterilization method.
Third, after sterilization, the transparency and size must be re-measured. Measuring only before sterilization is equivalent to not measuring at all. This step must be conducted before drop, internal pressure, and compatibility verification.
The next article discusses the inner liner of refrigerators and the inner drum of washing machines — what these parts fear most is not transparency, but resistance to detergents (ESC) and low-temperature shocks.
About Us
The selection process gets stuck, usually at a very specific step.
Whether an infusion container should be transparent or resistant to steam sterilization, whether a nucleation system was added but worries about the haze returning after steam, whether an ear hanger stress-cracking issue was checked for material and mold temperature — explaining clearly at which step it's stuck is much more useful than saying 'we need a good material'.
Ningbo Kolon New Materials Co., Ltd. produces modified polypropylene (PP) granules, covering three types of base materials: homopolymer, random copolymer, and impact copolymer, as well as modifications in directions such as transparency, radiation resistance, low exudation, filling, glass fiber reinforcement, toughening, and flame retardancy; it also trades in major petrochemical plant PP resins, by-product materials, and bulk materials.
